{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:05:14Z","timestamp":1779487514113,"version":"3.53.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004007","name":"Menopause Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004007","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.maturitas.2026.108923","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:22:49Z","timestamp":1774023769000},"page":"108923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT)"],"prefix":"10.1016","volume":"208","author":[{"given":"Chlo\u00e9","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Rouchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Hocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tremollieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2898-0381","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2026.108923_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.maturitas.2026.108923_bb0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.maturitas.2015.06.004","article-title":"Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife","volume":"81","author":"Gartoulla","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.maturitas.2022.08.003","article-title":"Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management","volume":"166","author":"Tr\u00e9mollieres","year":"2022","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.12.010","article-title":"Estrogen and bone health in men and women","volume":"99","author":"Cauley","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2026.108923_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12905-023-02788-0","article-title":"The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis","volume":"24","author":"Gu","year":"2024","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.maturitas.2026.108923_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women\u2019s health initiative investigators, risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2026.108923_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.3128","article-title":"Menopausal hormone therapy use among postmenopausal women","volume":"5","author":"Yang","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.maturitas.2026.108923_bb0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002: impact of the Women\u2019s Health Initiative study results","volume":"26","author":"Crawford","year":"2018","journal-title":"Menopause N. Y. N"},{"key":"10.1016\/j.maturitas.2026.108923_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.maturitas.2015.02.129","article-title":"Menopausal hormone therapy use in 17 European countries during the last decade","volume":"81","author":"Ameye","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.maturitas.2021.02.003","article-title":"Evaluation of menopausal hormone therapy use in Korea (2002\u22122013): a nationwide cohort study","volume":"146","author":"Park","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/13697137.2019.1593357","article-title":"Longitudinal impact of the Women\u2019s Health Initiative study on hormone therapy use in Australia","volume":"22","author":"Natari","year":"2019","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.108923_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/13697137.2015.1098610","article-title":"Time trends in breast cancer and menopause hormone therapy use in New Zealand","volume":"19","author":"Farmer","year":"2016","journal-title":"Climacteric J. Int. Menopause Soc."},{"key":"10.1016\/j.maturitas.2026.108923_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2023.107787","article-title":"Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021","volume":"175","author":"Sundell","year":"2023","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108270","article-title":"Trends in the use of menopausal hormone therapy in France, 2001\u20132023","volume":"197","author":"Amaro Costa","year":"2025","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.maturitas.2026.108923_bb0080","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"2017","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2026.108923_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2022.05.008","article-title":"Management of postmenopausal women: Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais (CNGOF) and Groupe d\u2019Etude sur la M\u00e9nopause et le Vieillissement (GEMVi) Clinical Practice Guidelines","volume":"163","author":"Tr\u00e9mollieres","year":"2022","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"the IMS Writing Group, 2016 IMS recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.108923_bb0095","series-title":"\u201cThe 2022 hormone therapy position statement of the North American Menopause Society\u201d Advisory panel, the 2022 hormone therapy position statement of the North American Menopause Society, Menopause N. Y. N 29","first-page":"767","year":"2022"},{"key":"10.1016\/j.maturitas.2026.108923_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101551","article-title":"Menopausal hormone therapy for the management of osteoporosis","volume":"35","author":"Gosset","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.108923_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/13697137.2016.1196047","article-title":"Revised global consensus statement on menopausal hormone therapy","volume":"19","author":"De Villiers","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.108923_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/13697137.2024.2394950","article-title":"Menopause and MHT in 2024: addressing the key controversies \u2013 an international menopause society white paper","volume":"27","author":"Panay","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.108923_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2053369120957514","article-title":"2020 Recommendations on hormone replacement therapy in menopausal women","volume":"26","author":"Hamoda","year":"2020","journal-title":"Post Reprod. Health"},{"key":"10.1016\/j.maturitas.2026.108923_bb0120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamainternmed.2016.2761","article-title":"for the Guideline Development Group for Menopause: Diagnosis and Management (NICE Clinical Guideline No. 23), Diagnosis and management of menopause: the National Institute of Health and Care Excellence (NICE) guideline","volume":"176","author":"Lumsden","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.maturitas.2026.108923_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108263","article-title":"Swedish physicians\u2019 knowledge of and prescribing practices for menopausal hormone therapy: a nationwide cross-sectional survey","volume":"197","author":"G\u00f6tze Eriksson","year":"2025","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.maturitas.2019.07.024","article-title":"Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: a survey of gynecologists in Belgium","volume":"128","author":"Rozenberg","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0135","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2026.108923_bb0140","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2026.108923_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.108096","article-title":"Real-world evaluation of treatment utilization by women experiencing vasomotor symptoms associated with menopause in the United States and Europe: findings from the REALISE study","volume":"189","author":"Kingsberg","year":"2024","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.108923_bb0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.medcli.2016.05.023","article-title":"Utilization of hormone replacement therapy in Spain: trends in the period 2000-2014","volume":"147","author":"Balad\u00e9 Mart\u00ednez","year":"2016","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.maturitas.2026.108923_bb0155","series-title":"The 2023 nonhormone therapy position statement of the North American Menopause Society, Menopause N. Y. N 30","first-page":"573","year":"2023"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T21:26:00Z","timestamp":1779485160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"alternative-id":["S0378512226001003"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.108923","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT)","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.108923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108923"}}